May 1 (Reuters) - Regeneron Pharmaceuticals and Sanofi will cut the net price of their expensive cholesterol drug for Express Scripts customers in exchange for greater patient access, with some ...
The Federal Trade Commission has reached a settlement with Express Scripts, one of the largest U.S. pharmacy benefit managers, over allegations it inflated drug prices to boost profits. The agreement ...
On February 4, 2026, the Federal Trade Commission (FTC) proposed to settle its enforcement action against leading pharmacy benefit manager (PBM) Express Scripts, going beyond the insulin products that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results